Roche Considers Divesting $1.9 Billion Cancer Data Startup
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
- Latest
- Trending
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Uber reports 21% gross bookings growth and 71% EBITDA rise in Q2 2024, eyes expansion in AV market.
Samsung's 8-layer HBM3E chips pass Nvidia's tests, setting stage for potential supply in late 2024 amid rising AI demand.
TopBuild Corp. announces 3.7% sales increase to $1.37B in Q2 2024. Key growth driven by pricing strategies, higher volumes, and ...
Dogecoin's price recently rebounded, suggesting signs of stabilization. Analyst Kaleo predicts a consolidation phase before a rally in early 2025.
Bitcoin's recent fall below $56,000 shakes investor confidence. Is it a temporary pullback or an alarming signal?
Assurant reports a 21% increase in Q2 profit driven by robust global housing performance and higher investment returns.
VF Corp's Q1 revenue fell less than expected, boosted by strong demand in China and streamlined inventory. Shares rose 7% ...
Rivian posts a Q2 loss of $1.46 per share, missing estimates as production declines; teams up with Volkswagen in a ...
Airbnb shares drop 13% following a disappointing Q3 revenue forecast, despite beating Q2 revenue estimates. Consumer headwinds affect demand.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.